Search Results

There are 6324 results for: content related to: Exacerbation of myasthenia gravis with voriconazole

  1. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by aspergillus fumigatus

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 5, May 2011, Pages: 1745–1759, Wu Xiang-Gen, Yang Li-Na, Xin Meng and Jiang Hao-Ran

    Version of Record online : 24 NOV 2010, DOI: 10.1002/jps.22402

  2. Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1373–1382, Dr James A. Dowell, Dr Jennifer Schranz, Dr Alice Baruch and Dr Grover Foster

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005281234

  3. Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia

    Mycoses

    Volume 55, Issue 3, May 2012, Pages: 244–256, Daoud Al-Badriyeh, Danny Liew, Kay Stewart and David C. M. Kong

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1439-0507.2011.02074.x

  4. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients

    Transplant Infectious Disease

    Volume 17, Issue 2, April 2015, Pages: 250–258, D.J. Wojenski, G.T. Bartoo, J.A. Merten, R.A. Dierkhising, M.R. Barajas, R.A. el-Azhary, J.W. Wilson, M.F. Plevak, W.J. Hogan, M.R. Litzow, M.M. Patnaik, R.C. Wolf and S.K. Hashmi

    Version of Record online : 26 MAR 2015, DOI: 10.1111/tid.12367

  5. Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 73–84, Mr Ping Liu, Dr Grover Foster, Mr Rober R. LaBadie, Dr Mari J. Gutierrez and Dr Amarnath Sharma

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007309703

  6. Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 751–759, K. Ona and D.H. Oh

    Version of Record online : 20 JUL 2015, DOI: 10.1111/bjd.13862

  7. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 82–87, Soo-Han Choi, Soo-Youn Lee, Ji-Young Hwang, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo and Yae-Jean Kim

    Version of Record online : 8 AUG 2012, DOI: 10.1002/pbc.24262

  8. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

    Mycoses

    Volume 55, Issue 6, November 2012, Pages: 483–492, Zdenek Racil, Jana Winterova, Michal Kouba, Pavel Zak, Ludmila Malaskova, Lucie Buresova, Martina Toskova, Martina Lengerova, Iva Kocmanova, Barbora Weinbergerova, Shira Timilsina, Monika Rolencova, Petr Cetkovsky and Jiri Mayer

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1439-0507.2012.02186.x

  9. You have free access to this content
    Antifungal prophylaxis in haematology patients: the role of voriconazole

    Clinical Microbiology and Infection

    Volume 18, Issue s2, April 2012, Pages: 1–15, Y. Hicheri, G. Cook and C. Cordonnier

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1469-0691.2012.03772.x

  10. CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 7, July 2014, Pages: 703–718, Aniwaa Owusu Obeng, Eric F. Egelund, Abdullah Alsultan, Charles A. Peloquin and Julie A. Johnson

    Version of Record online : 7 FEB 2014, DOI: 10.1002/phar.1400

  11. Institutional Experience with Voriconazole Compared with Liposomal Amphotericin B as Empiric Therapy for Febrile Neutropenia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 7, July 2007, Pages: 970–979, Dr. Nadine Shehab, Dr. Daryl D. DePestel, Dr. Emily R. Mackler, Dr. Curtis D. Collins, Ms. Kathleen Welch and Dr. Harry P. Erba

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.7.970

  12. You have free access to this content
    Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects

    British Journal of Clinical Pharmacology

    Volume 65, Issue 4, April 2008, Pages: 531–539, Emma Andrews, Bharat D. Damle, Annie Fang, Grover Foster, Penelope Crownover, Robert LaBadie and Paul Glue

    Version of Record online : 21 FEB 2008, DOI: 10.1111/j.1365-2125.2007.03084.x

  13. You have free access to this content
    Poster Abstracts

    Mycoses

    Volume 55, Issue s4, June 2012, Pages: 95–338,

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1439-0507.2012.02206.x

  14. An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger Than 2 Years Old

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Accepted manuscript online: 22 AUG 2016, Tracy N Zembles, Nathan E Thompson, Peter L Havens, Bruce A Kaufman and Anna R Huppler

    DOI: 10.1002/phar.1829

  15. Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 195–203, SeungHwan Lee, Bo-Hyung Kim, Won-Seok Nam, Seo Hyun Yoon, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang and Kyung-Sang Yu

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395510

  16. Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 235–243, Dr Keith Tan, Mr Nigel Brayshaw, Dr Konrad Tomaszewski, Dr Peter Troke and Dr Nolan Wood

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005283837

  17. You have free access to this content
    Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014

    Internal Medicine Journal

    Volume 44, Issue 12b, December 2014, Pages: 1364–1388, M. M. Chau, D. C. M. Kong, S. J. van Hal, K. Urbancic, J. A. Trubiano, M. Cassumbhoy, J. Wilkes, C. M. Cooper, J. A. Roberts, D. J. E. Marriott and L. J. Worth

    Version of Record online : 8 DEC 2014, DOI: 10.1111/imj.12600

  18. Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study

    The Journal of Clinical Pharmacology

    Volume 42, Issue 4, April 2002, Pages: 395–402, Dr. Hillard M. Lazarus, Dr. Jeffrey L. Blumer, Dr. Saul Yanovich, Dr. Haran Schlamm and Dr. Alain Romero

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700222011445

  19. Concurrent Administration of Sirolimus and Voriconazole: A Pilot Study Assessing Safety and Approaches to Appropriate Management

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 6, June 2008, Pages: 719–729, Dorothy Surowiec, Daryl D. DePestel and Peggy L. Carver

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.6.719

  20. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin

    Mycoses

    Volume 41, Issue 7-8, September 1998, Pages: 309–319, A. Wildfeuer, H. P. Seidl, I. Paule and A. Haberreiter

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1439-0507.1998.tb00344.x